Abstract
1. The high efficacy of ACE inhibitors to potentiate the actions of kinins might be explained by a hypothetical compartment in which B 2-receptors are colocalized with kinin degrading enzymes. To demonstrate the functional consequence of such a compartment we compared the myocardial uptake and the persistence of action of bradykinin under the influence of kininase inhibitors. 2. Bradykinin-induced vasodilation and uptake of tritiated bradykinin were studied in perfused rat hearts during inhibition of ACE and aminopeptidase P. B 2-receptors were localized by immuno-gold labelling and electron-microscopy. 3. The EC 50 of bradykinin-induced vasodilation (5.1 ± 0.8 nM) was shifted to 14 fold lower concentrations during inhibition of both kininases. The maximum persistence of vasodilation after termination of bradykinin application (half-life 112 ± 20 s) was increased by kininase inhibitors to 398 ± 130 s. This prolongation was reversed when B 2-receptors were blocked simultaneously with the termination of bradykinin infusion. 4. Tritiated bradykinin (perfused for 1 rain) was partially (1.7 ± 0.24%) retained by the myocardium and consecutively released with a half-life of 70 ± 9 s. Kinin uptake was increased during kininase inhibition (7.7 ± 2.6%), and was normalized by HOE 140 (2.0 ± 0.34%), or when a tritiated B 2-receptor antagonist (NPC 17731) was used as label. 5. B 2-receptors were localized in plasmalemmal and cytosolic vesicles of capillary endothelium. 6. Bradykinin is locally incorporated and can associate with B 2-receptors repeatedly when kinin breakdown is inhibited. This is the kinetic and functional consequence of a colocalization of kininases and B 2-receptors in a compartment constituted by endothelial membrane vesicles.
Original language | English |
---|---|
Journal | British Journal of Pharmacology |
Volume | 138 |
Issue number | 2 |
Pages (from-to) | 310-316 |
Number of pages | 7 |
ISSN | 0007-1188 |
DOIs | |
Publication status | Published - 01.01.2003 |
Research Areas and Centers
- Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)